Preview Newsletter
Opioid Litigation Media Update 8/16/18
-
President Trump threatens to sue opioid makers, says crisis is 'warfare'
Aug 16, 2018 | USA Today
By John Fritze
President Donald Trump on Thursday threatened to sue drug makers that manufacture opioids, mimicking an approach embraced by several states wrestling with huge increases in overdose deaths. -
Trump urges Sessions to bring federal suit against opioid makers
Aug 16, 2018 | The Hill
By Jordan Fabian and Nathaniel Weixel
President Trump on Thursday urged Attorney General Jeff Sessions to bring a federal lawsuit against drug companies that produce opioids. -
Trump pushes U.S. lawsuit against drug companies over opioids
Aug 16, 2018 | Reuters
By Steve Holland
U.S. President Donald Trump on Thursday again pressed U.S. Attorney General Jeff Sessions to sue drug companies over the nation’s ongoing opioids crisis. -
Trump wants Sessions to target opioid manufacturers with a federal suit
Aug 16, 2018 | Associated Press
By Darlene Superville
President Trump is asking Atty. Gen. Jeff Sessions to file a federal lawsuit against certain companies that supply and manufacture opioids. -
Trump Says He Wants Federal Lawsuit Against Opioid Makers
Aug 16, 2018 | Bloomberg
By Justin Sink and Anna Edney
President Donald Trump said Thursday he wants the U.S. government to sue pharmaceutical companies that manufacture opioids as part of his efforts to halt an epidemic of drug addiction. -
Trump tells Sessions to sue certain opioid companies
Aug 16, 2018 | CNN
By Jeremy Diamond
President Donald Trump urged his Attorney General Jeff Sessions to sue certain pharmaceutical companies that have contributed to the opioid crisis in the United States. -
Trump Calls On Justice Department to Sue Opioid Companies
Aug 16, 2018 | Wall Street Journal
By Rebecca Ballhaus
President Trump on Thursday called on his attorney general to sue opioid companies, his latest move in an administration-wide effort to combat the opioid epidemic. -
Trump asks Sessions to sue drug companies (Video)
Aug 16, 2018 | National Programming
By CNN
Video Link: https://www.cnn.com/videos/politics/2018/08/16/jeff-sessions-donald-trump-federal-lawsuit-drug-companies-sot-vpx.cnn -
Trump Plans to Launch Lawsuit Against Opioid Makers (Video)
Aug 16, 2018 | National Programming
By Bloomberg Markets
Video Link: https://www.bloomberg.com/news/videos/2018-08-16/trump-plans-to-launch-lawsuit-against-opioid-makers-video -
Shepard Smith Reporting (Video)
| National TV
By Fox News
Video Link: https://app.criticalmention.com/app/#clip/view/74a8f28b-daa4-4270-8cf1-4a91f76b1401?token=22cfdd8c-efee-4124-9163-4508d3733b29 -
Trump administration cracking down on production of prescription opioids
Aug 16, 2018 | The Hill
By Jessie Hellman
The Trump administration is using new powers to propose a significant decrease in how many opioids drug companies can manufacture in the U.S. in 2019. -
Trump administration proposes production quota cuts for six opioids
Aug 16, 2018 | Reuters
By Tim Ahmann and Steve Holland
The Trump administration on Thursday proposed that U.S. drugmakers cut production quotas of the six most abused opioids by 10 percent next year to fight a nationwide addiction crisis. -
Drug Agency Rule to Slash Opioid Production
Aug 16, 2018 | U.S. News
By Gabrielle Levy
THE GOVERNMENT IS seeking to tackle the opioid crisis with a crackdown on the production of prescription opioids permitted to be manufactured next year. -
DOJ, DEA Seek to Crack Down on Opioid Production
Aug 16, 2018 | The Daily Beast
By Staff
The Department of Justice and Drug Enforcement Administration have proposed decreases in manufacturing quotas for several common opioids by an average of 10 percent in 2019, according to a DOJ press release. -
White House proposing cuts in opioid production
Aug 16, 2018 | Seeking Alpha
By Douglas W. House
Aimed at fighting the U.S. opioid crisis, the Trump administration is proposing production cuts in the most-abused compounds, oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl, by 10% next year.
President Trump Statements
DEA Anouncement
-
President Trump threatens to sue opioid makers, says crisis is 'warfare'
Aug 16, 2018 | USA Today
By John Fritze
President Donald Trump on Thursday threatened to sue drug makers that manufacture opioids, mimicking an approach embraced by several states wrestling with huge increases in overdose deaths.
Speaking during a Cabinet meeting, the president asked Attorney General Jeff Sessions to bring a lawsuit against companies marketing opioids and also tasked him with looking into drug trafficking from China and Mexico, which he accused of “sending their garbage and killing our people.”
“It’s almost a form of warfare,” Trump said.
The federal government has already joined several lawsuits filed by state governments. New York state this week was the latest to sue Purdue Pharma, the maker of OxyContin, alleging that the company downplayed the risk of addiction in its marketing.
Trump declared the opiopid crisis a national health emergency in October. The Centers for Disease Control reported on Wednesday that 72,000 Americans died of a drug overdose last year, a 10 percent increase over 2016.
-
Trump urges Sessions to bring federal suit against opioid makers
Aug 16, 2018 | The Hill
By Jordan Fabian and Nathaniel Weixel
President Trump on Thursday urged Attorney General Jeff Sessions to bring a federal lawsuit against drug companies that produce opioids.
Speaking during a Cabinet meeting, the president also asked his embattled attorney general to look at opioid drugs coming into the country from China and Mexico, saying those countries were “sending their garbage and killing our people.”
“It’s almost a form of warfare,” Trump told Sessions.
When the attorney general agreed, the president responded: “I’d be very, very firm on that. It’s a disgrace, and we can stop it.”
Several states have already filed lawsuits, which the Justice Department has backed, against drug companies that manufacture opioid painkillers.
But to date, much of the legal action has come against domestic manufacturers and distributors, rather than foreign countries.
A separate federal suit would escalate the government's efforts to combat the drugs and risk a tense standoff with major pharmaceutical companies.
Trump's relationship with drug companies is already contentious, as he has repeatedly attacked the industry over high drug prices. The administration is in the process of instituting drug price reforms.
Opioid makers and distributors have been hit with hundreds of lawsuits by states, counties and cities accusing them of using deceptive marketing to sell painkillers.
Purdue Pharmaceuticals, the manufacturer of OxyContin, is facing lawsuits in 27 states for its alleged role in the opioid crisis.
Nearly 49,000 people died from opioid overdoses in the past year, according to the Centers for Disease Control and Prevention.
The exchange between Trump and Sessions was made more remarkable due to the strained relationship between the two over the Russia investigation.
The president tweeted just last week that his own attorney general was "scared stiff" due to his unwillingness to step in to stop the probe, which is examining whether the Trump campaign colluded with Moscow's election interference efforts in 2016.
Trump consistently lashed out at Sessions for his decision to recuse himself from the probe.
-
Trump pushes U.S. lawsuit against drug companies over opioids
Aug 16, 2018 | Reuters
By Steve Holland
U.S. President Donald Trump on Thursday again pressed U.S. Attorney General Jeff Sessions to sue drug companies over the nation’s ongoing opioids crisis.
“I’d like to bring a federal lawsuit against those companies,” Trump said during a meeting of his Cabinet at the White House.
-
Trump wants Sessions to target opioid manufacturers with a federal suit
Aug 16, 2018 | Associated Press
By Darlene Superville
President Trump is asking Atty. Gen. Jeff Sessions to file a federal lawsuit against certain companies that supply and manufacture opioids.
Speaking during a Cabinet meeting Thursday, Trump said he's directing Sessions to file a separate lawsuit, rather than joining existing lawsuits filed by states affected by the spread of the often-lethal, highly addictive drugs.
Trump is asking Sessions to look out for opioids coming into the U.S. from China and Mexico, saying those countries are "sending their garbage and killing our people."
Trump added: "It's almost a form of warfare."
It was not immediately clear if or when a federal suit would be filed. A barrage of suits have been filed nationwide against distributors and manufacturers in recent months amid the opioid epidemic.
-
Trump Says He Wants Federal Lawsuit Against Opioid Makers
Aug 16, 2018 | Bloomberg
By Justin Sink and Anna Edney
President Donald Trump said Thursday he wants the U.S. government to sue pharmaceutical companies that manufacture opioids as part of his efforts to halt an epidemic of drug addiction.
Trump said he’d like to bring a federal lawsuit, rather than just join existing litigation against the drugmakers.
“Some states have done it,” Trump said during a Cabinet meeting at the White House. “But I’d like a lawsuit to be brought against these companies that are really sending opioids at a level -- it shouldn’t be happening. So highly addictive. People go into a hospital with a broken arm, they come out, they’re a drug addict.”
Drugmakers such as Purdue Pharma LP and Johnson & Johnson that sell opioid painkillers face hundreds of lawsuits filed by states, cities, counties, Native American tribes and labor unions as the epidemic of addiction continues to rage in the U.S. The Centers for Disease Control and Prevention said preliminary estimates indicate that almost 72,000 Americans died from opioid overdoses last year, a figure that has been rising for years.
Trump didn’t offer more detail on a possible a lawsuit.
Republican leaders of the House Energy and Commerce Committee wrote Aug. 3 to opioid manufacturers Purdue, Insys Therapeutics Inc. and Mallinckrodt Plc, asking about their role in the epidemic. Lawmakers have also focused on pharmaceutical distributors such as McKesson Corp. and Cardinal Health Inc.
Purdue, J&J, Insys, Mallinckrodt and the Justice Department didn’t immediately respond to requests for comment.Chinese Imports
Trump also asked the Justice Department to address the flow of synthetic opioids from China. The drugs have played an increasing role in overdose deaths in the U.S. as users turn from prescribed pills to often illicitly obtained compounds from overseas, manufactured from a variety of producers.
Trump asked Attorney General Jeff Sessions to do “whatever you can do from a legal standpoint, whether it’s litigation, lawsuits, with people and companies.”
“In China you have some pretty big companies sending that garbage and killing our people,” Trump said. “It’s almost a form of warfare. And I’d like to do whatever you can do legally to stop it from China and from Mexico.”
Sessions said that the Justice Department had identified companies shipping some of the illegal drugs and was taking action.
“We’re returning indictments now against distributors from China,” Sessions told Trump, though added that some of the imports were still coming in through smuggling.
-
Trump tells Sessions to sue certain opioid companies
Aug 16, 2018 | CNN
By Jeremy Diamond
President Donald Trump urged his Attorney General Jeff Sessions to sue certain pharmaceutical companies that have contributed to the opioid crisis in the United States.
"I'd also like to ask you to bring a major lawsuit against the drug companies on opioids," Trump told Sessions during a Cabinet meeting on Thursday. "Some states have done it. But I'd like a lawsuit to be brought against these companies that are really sending opioids at a level that it shouldn't be happening."
The Justice Department has joined state lawsuits against opioid companies that officials believe have helped fuel a national opioid crisis, Sessions said, but Trump said he would like the Justice Department to pursue a separate federal lawsuit against certain drug companies. Trump did not specify which companies he would like the Justice Department to sue.
Sessions said the Justice Department is "looking at various different legal avenues to go after abusive companies."
"You've made clear you want us to sue and use legal process against drug companies that are abusing the law for some time now," Sessions said.
Trump also urged Sessions to take legal action against foreign companies, especially from China, that have contributed to the deadly flow of fentanyl into the US.
"In China, you have some pretty big companies sending that garbage and killing our people. It's almost like a form of warfare," Trump said. "I'd like you to do what you can legally."
"We absolutely will," Sessions replied, adding that the Justice Department is in the process of "returning indictments" against Chinese companies tied to the fentanyl.
Sessions also noted that the Justice Department has indicted 170 physicians who have unlawfully prescribed opioids.
The back-and-forth between Trump and Sessions came just two days after Trump unleashed his latest public criticism of his attorney general, tweeting that "if we had a real Attorney General," the special counsel's investigation "would never have been started."
-
Trump Calls On Justice Department to Sue Opioid Companies
Aug 16, 2018 | Wall Street Journal
By Rebecca Ballhaus
President Trump on Thursday called on his attorney general to sue opioid companies, his latest move in an administration-wide effort to combat the opioid epidemic.
In a cabinet meeting Thursday at the White House, Mr. Trump asked Attorney General Jeff Sessions to bring federal lawsuits against certain companies supplying opioids to hospitals, rather than joining state lawsuits. He also charged Mr. Sessions with investigating fentanyl coming from China and Mexico, countries he said were “sending their garbage and killing our people.”
“It’s almost a form of warfare,” Mr. Trump said. Mr. Sessions said he would follow Mr. Trump’s request.
“I’d be very firm on that,” Mr. Trump added. “It’s a disgrace and we can stop it.”
Mr. Trump earlier this year called for new steps to combat the opioid epidemic. Those included pushing to reduce opioid prescriptions by a third over three years, asking the Justice Department to seek more death-penalty cases against drug traffickers under current law, and calling for federal support to expand the availability of overdose-reversal medication.
The Justice Department in April requested to join settlement talks in sprawling government litigation against the makers and distributors of prescription painkillers.
More than a dozen states, including Arkansas, Ohio, New Jersey and Delaware, as well as municipalities and Native American tribes have filed more than 1,000 lawsuits against drugmakers, claiming an aggressive marketing of prescription painkillers contributed to the opioid addiction epidemic.
Among the companies targeted are Purdue Pharma LP, Johnson & Johnson , Endo International PLC and Teva Pharmaceuticals Industries Ltd. The suits generally claim the companies misrepresented the addictive risk of their medicines in marketing materials, and seek to recoup the cost of opioid addiction born by the government entities.
Many suits also targeted drug distributors, including Amerisource Bergen Corp., Cardinal Health Inc. and McKesson Corp. , contending the companies failed to properly control shipments of opioids to pharmacies.
The companies have denied the allegations and said their marketing and sales practices are appropriate.
New York this week became the latest state to file such a suit against Purdue. The company said in response, “We believe it is inappropriate for the state to substitute its judgment for the judgment of the regulatory, scientific and medical experts at FDA.”
A federal district judge in Ohio overseeing hundreds of the local cases has pushed hard for a settlement and made it clear protracted litigation won’t help solve the opioid crisis.
The judge, Dan Polster, has scheduled the first trial for September 2019 but said in court earlier this month he thinks a trial “will accomplish zero” toward a broader resolution. If the defendant drug makers and distributors “go to war with every government in this country,” he said, there’s a chance “everyone is going to go into bankruptcy.”
Drug overdose deaths soared to more than 72,000 in 2017, a record, according to preliminary data released this week by the Centers for Disease Control and Prevention. That compares with about 66,000 deaths in 2016. The report shows how much deadlier opioid drugs have become, with the largest number of deaths coming from synthetic opioids such as fentanyl.
But the data also show a slight decline in deaths in the last month of 2017 and January 2018, suggesting that efforts to prevent opioid use and treat addiction may be starting to have an effect.
Mr. Trump’s order to his attorney general came after he escalated his criticism of Mr. Sessions in recent days. Earlier this week, he said the attorney general was “missing in action” during the investigation into Russian interference in the 2016 U.S. election—from which Mr. Sessions recused himself last year—and said Mr. Sessions was “scared stiff.”
Presidents typically don’t order their attorneys general to bring specific lawsuits, to avoid the perception they are interfering in Justice Department matters.
Combating the drug-abuse crisis has been a top priority for Mr. Sessions, who has taken aim at doctors who negligently overprescribe addictive painkillers, as well as online pill peddlers and drug-trafficking gangs.
The Justice Department has already taken some steps toward punishing prescription drug companies. On Thursday, officials proposed cutting manufacturing quotas for six commonly abused prescription opioids, including oxycodone, hydrocodone and fentanyl, by an average of 10% for 2019.
Earlier this year, the department threw its support behind the state and local lawsuits against manufacturers and distributors by filing a so-called statement of interest in the case.
The department had no immediate comment Thursday on Mr. Trump’s request for a federal lawsuit.
-
Trump asks Sessions to sue drug companies (Video)
Aug 16, 2018 | National Programming
By CNN
Video Link: https://www.cnn.com/videos/politics/2018/08/16/jeff-sessions-donald-trump-federal-lawsuit-drug-companies-sot-vpx.cnn
Rough Transcript: Unavailable
-
Trump Plans to Launch Lawsuit Against Opioid Makers (Video)
Aug 16, 2018 | National Programming
By Bloomberg Markets
Video Link: https://www.bloomberg.com/news/videos/2018-08-16/trump-plans-to-launch-lawsuit-against-opioid-makers-video
Rough Transcript: getting some comments from the president himself on lawsuits against opioid drug companies. >> that's right. we heard the president today at the cabinet meeting in washington say he would like doj to look into a federal lawsuit against some of these pharmaceutical companies that manufacture opioids. that would be separate from many of the state -- there are hundreds of state and county and city lawsuits going on right now. he wants the federal government to jump in and do something on its own. amanda: that could be just rhetoric. is there any reason to believe there is a case here against companies? obviously, in some cases, over prescribed medicine, but legal medicine? >> there's no reason to believe there is a case. we have not heard yet from doj. i have asked them whether there is something that they might do or if this is something there looking into for the president. have not heard yet back. shery: in may, we saw american patients first, a plan introduced by the president. how can we say these plans are developing so far? >> there have been a lot of steps taken, a lot of policy steps that are in the weeds sometimes, looking at ways to be able to help medicare particularly bring down drug prices. there are areas in medicare that can be experimented with. that is one way they will try to tackle this. most recently, the hhs secretary said they would help insurance companies and pharmacy benefit managers to be able to negotiate in a certain part of medicare for certain drugs that are administers in a doctors office or a hospital. they are taking steps like that. they are small chunks each time. they are try to figure out ways, rather than one big effort. there are a lot of little efforts going on.
-
Shepard Smith Reporting (Video)
| National TV
By Fox News
Video Link: https://app.criticalmention.com/app/#clip/view/74a8f28b-daa4-4270-8cf1-4a91f76b1401?token=22cfdd8c-efee-4124-9163-4508d3733b29
Rough Transcript: president trump telling attorney general sessions bring lawsuits against companies that make opioids. the president accusing chinese and medication can companies of worsening america 79 opioid crisis by sending powerful painkillers in to the u.s. >> in china have you some pretty big companies sending that garbage and killing our people. it's almost a form of warfare and i would like to do whatever you can do legally to stop it from china and from mexico. >> shepard: several states have already filed lawsuits against opioidmakers and distributers. the fox business network blake burman with the news live at the white house. blake? >> hi there, shepard. we have seen states engage in lawsuits against pharmaceutical companies the makers of opioid drugs all across the country. in fact, just this week new york state sued the manufacturer behind the popular drug oxycontin. in some cases the federal government, the department of justice has thrown its weight behind those lawsuits. but, today, during a cabinet meeting, president trump said he wants to go a step further than that. these were the instructions from president Trump to AG Jeff Sessions
-
Trump administration cracking down on production of prescription opioids
Aug 16, 2018 | The Hill
By Jessie Hellman
The Trump administration is using new powers to propose a significant decrease in how many opioids drug companies can manufacture in the U.S. in 2019.
The Justice Department and Drug Enforcement Administration (DEA) are proposing an average 10 percent decrease next year in the manufacturing quotas for six frequently misused opioids.
“We’ve lost too many lives to the opioid epidemic and families and communities suffer tragic consequences every day,” said acting DEA Administrator Uttam Dhillon.
“This significant drop in prescriptions by doctors and DEA’s production quota adjustment will continue to reduce the amount of drugs available for illicit diversion and abuse while ensuring that patients will continue to have access to proper medicine.”
A final rule released in July gave the agency the authority to consider a drug's potential for abuse when setting its annual opioid production limits.
Before the rule was finalized, the agency could only consider factors like past sales and estimated demand.
Experts say the overproduction of opioids has contributed significantly to the ongoing opioid abuse epidemic.
The proposed quotas for 2019 would decrease manufacturing for oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl.
Attorney General Jeff Sessions said the decrease should help reduce opioid prescribing rates.
"Cutting opioid production quotas by an average of ten percent next year will help us continue that progress and make it harder to divert these drugs for abuse," he said in a statement.
The proposed quotas will go through a 30 day comment period before being finalized.
-
Trump administration proposes production quota cuts for six opioids
Aug 16, 2018 | Reuters
By Tim Ahmann and Steve Holland
The Trump administration on Thursday proposed that U.S. drugmakers cut production quotas of the six most abused opioids by 10 percent next year to fight a nationwide addiction crisis.
In a statement, the U.S. Justice Department and Drug Enforcement Administration (DEA) said the proposed cut would be in keeping with President Donald Trump’s effort to cut opioid prescription fills by one-third within three years.
Trump on Thursday also pressed U.S. Attorney General Jeff Sessions to sue drug manufacturers over the opioid crisis.
“I’d like to bring a federal lawsuit against those companies,” Trump said during a meeting of his Cabinet at the White House. He did not name the companies.
Addiction to opioids - mainly prescription painkillers, heroin and fentanyl - is a growing U.S. problem, especially in rural areas. According to the Centers for Disease Control and Prevention, opioids were involved in more than 49,000 deaths in the country last year.
The Justice Department and the DEA said they are proposing to cut production quotas for oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine, and fentanyl by 7 percent to 15 percent, depending on the compound, in 2019.
Hundreds of lawsuits have been filed by states, counties and cities against opioid manufacturers including Purdue Pharmaceuticals LP, Endo International Plc (ENDP.O), Mallinckrodt Plc (MNK.N) and Johnson & Johnson (JNJ.N) seeking to hold them responsible for contributing to the epidemic.
Those companies were not immediately available for comment.
In March, Trump unveiled a plan to get tough on opioids, including cutting opioid prescriptions by changing federal programs, funding for other initiatives and stiffer sentencing laws for drug dealers.
He also suggested the death penalty for dealers, a proposal that has gained little support from drug abuse and judicial experts.
-
Drug Agency Rule to Slash Opioid Production
Aug 16, 2018 | U.S. News
By Gabrielle Levy
THE GOVERNMENT IS seeking to tackle the opioid crisis with a crackdown on the production of prescription opioids permitted to be manufactured next year.
In a release, the Department of Justice and the U.S. Drug Enforcement Administration proposes slashing "manufacturing quotas for the six most frequently misused opioids for 2019 by an average ten percent as compared to the 2018 amounted," according to an advance version of the release viewed by Axios.
The release notes that the proposal, part of President Donald Trump's Safe Prescribing Plan, would advance a federal effort to sharply reduce opioid abuse by limiting the drugs' availability.
"The Notice of Proposed Rulemaking (NPRM) marks the third straight year of proposed reductions, which help reduce the amount of drugs potentially diverted for trafficking and used to facilitate addiction," the release reads, according to Axios. "Ultimately, revised limits will encourage vigilance on the part of opioid manufacturers, help DEA respond to the changing drug threat environment, and protect the American people from potential addictive drugs while ensuring that the country has enough opioids for legitimate medical, scientific, research, and industrial needs."
Abuse of prescription opioids, however, is a fraction of the epidemic, with far more opioid-related deaths coming as a result of synthetic opioids such as fentanyl. Last year, according to National Institute of Drug Abuse figures, synthetic opioids were invoked in about 30,000 overdose deaths, a sharp spike from only about 5,000 in 2014 and more than heroin and prescription opioids combined.
-
DOJ, DEA Seek to Crack Down on Opioid Production
Aug 16, 2018 | The Daily Beast
By Staff
The Department of Justice and Drug Enforcement Administration have proposed decreases in manufacturing quotas for several common opioids by an average of 10 percent in 2019, according to a DOJ press release. They have proposed reducing the production of fentanyl, hydrocodone, hydromorphone, morphine, oxycodone, and oxymorphone. This is the third year in a row of proposed cuts. Meanwhile, opioid deaths are skyrocketing. The National Institute on Drug Abuse estimated that 49,068 people had deaths involving opioids in 2017, up from 42,249 in 2016. The Centers for Disease Control and Prevention estimated that 72,300 people died of drug overdoses last year. The release said the cuts will “help reduce the amount of drugs potentially diverted for trafficking and used to facilitate addiction” and “encourage vigilance on the part of opioid manufacturers.” It also said the country will still have enough opioids for legitimate medical, scientific, research, and industrial purposes.
-
White House proposing cuts in opioid production
Aug 16, 2018 | Seeking Alpha
By Douglas W. House
Aimed at fighting the U.S. opioid crisis, the Trump administration is proposing production cuts in the most-abused compounds, oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl, by 10% next year.
The U.S. Department of Justice and the Drug Enforcement Administration say the proposed reductions are inline with the President's goal to trim opioid prescriptions by 1/3 within the next three years. They are proposing production cuts of 7 - 15% in 2019.
Trump is also encouraging AG Jeff Sessions to sue drug makers over their role in the crisis.
President Trump Statements
DEA Anouncement
Add recipients
Suggested